685 related articles for article (PubMed ID: 7541892)
1. [Prophylaxis against mycoses in neutropenic patients].
Arning M; Aul C
Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
[TBL] [Abstract][Full Text] [Related]
2. Management of mycoses in surgical patients -- review of the literature.
Holzheimer RG; Dralle H
Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
[TBL] [Abstract][Full Text] [Related]
4. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
Kibbler CC
Mycoses; 1999; 42 Suppl 2():121-4. PubMed ID: 10865918
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
Glasmacher A; Prentice AG
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of fungal infections in children and adolescents with cancer].
Groll AH; Ritter J; Müller FM
Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
[TBL] [Abstract][Full Text] [Related]
7. Strategies for managing systemic fungal infection and the place of itraconazole.
Potter M
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i49-i54. PubMed ID: 16120634
[TBL] [Abstract][Full Text] [Related]
8. [Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
Burgaleta C
Rev Clin Esp; 1995 Oct; 195 Suppl 3():31-7. PubMed ID: 9441303
[No Abstract] [Full Text] [Related]
9. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.
Kanda Y; Yamamoto R; Chizuka A; Hamaki T; Suguro M; Arai C; Matsuyama T; Takezako N; Miwa A; Kern W; Kami M; Akiyama H; Hirai H; Togawa A
Cancer; 2000 Oct; 89(7):1611-25. PubMed ID: 11013378
[TBL] [Abstract][Full Text] [Related]
10. Fungal infections in cancer patients: an escalating problem.
Samonis G; Bafaloukos D
In Vivo; 1992; 6(2):183-93. PubMed ID: 1525339
[TBL] [Abstract][Full Text] [Related]
11. Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases.
Martino R; Nomdedéu J; Altés A; Sureda A; Brunet S; Martínez C; Domingo-Albós A
Bone Marrow Transplant; 1994 Mar; 13(3):265-9. PubMed ID: 8199569
[TBL] [Abstract][Full Text] [Related]
12. [Azole antifungal agents in the prevention of fungal infections in neutropenic patients and bone marrow graft recipients].
Lortholary O; Dupont B
Ann Med Interne (Paris); 1997; 148(3):258-67. PubMed ID: 9255336
[TBL] [Abstract][Full Text] [Related]
13. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
[TBL] [Abstract][Full Text] [Related]
14. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
[TBL] [Abstract][Full Text] [Related]
15. [Antifungal prophylaxis in neutropenic patients].
Cornely OA; Ullmann AJ; Karthaus M
Wien Med Wochenschr; 2001; 151(3-4):73-9. PubMed ID: 11789422
[TBL] [Abstract][Full Text] [Related]
16. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
[TBL] [Abstract][Full Text] [Related]
17. A survey of anti-fungal management in lung transplantation.
Dummer JS; Lazariashvilli N; Barnes J; Ninan M; Milstone AP
J Heart Lung Transplant; 2004 Dec; 23(12):1376-81. PubMed ID: 15607667
[TBL] [Abstract][Full Text] [Related]
18. Antifungal prophylaxis to prevent invasive mycoses among bone marrow transplantation recipients.
Gubbins PO; Bowman JL; Penzak SR
Pharmacotherapy; 1998; 18(3):549-64. PubMed ID: 9620106
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].
van't Wout JW; Novakova I; Verhagen CA; Fibbe WE; de Pauw BE; van der Meer JW
Med Klin (Munich); 1991 Dec; 86 Suppl 1():11-3. PubMed ID: 1663200
[TBL] [Abstract][Full Text] [Related]
20. [Prevention of mycotic infections in oncology patients with regard to the toxicity of antimycotic agents].
Doubek M; Mayer J; Horký D; Doubek J; Rácil Z; Vorlícek J
Vnitr Lek; 2002 Mar; 48(3):248-54. PubMed ID: 11968587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
